{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:22:03Z","timestamp":1794558123086,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019535","name":"Texas Tech University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.drugalcdep.2026.113192","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T15:31:49Z","timestamp":1778340709000},"page":"113192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Dose and age matter: Xylazine prevents age-dependent fentanyl lethality in rats"],"prefix":"10.1016","volume":"285","author":[{"given":"Julio D.","family":"Zuarth-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira","family":"Zolali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yash","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9644-0750","authenticated-orcid":false,"given":"Samuel","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2026.113192_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110993","article-title":"Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice","volume":"253","author":"Acosta-Mares","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"10.1016\/j.drugalcdep.2026.113192_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bph.15580","article-title":"Understanding and countering opioid-induced respiratory depression","volume":"180","author":"Bateman","year":"2023","journal-title":"Br. J. Pharm."},{"issue":"5","key":"10.1016\/j.drugalcdep.2026.113192_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/ADM.0000000000001185","article-title":"Fentanyl absorption, distribution, metabolism, and excretion: narrative review and clinical significance related to illicitly manufactured fentanyl","volume":"17","author":"Bird","year":"2023","journal-title":"J. Addict. Med"},{"issue":"11","key":"10.1016\/j.drugalcdep.2026.113192_bib4","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41386-023-01601-8","article-title":"Overdose mortality rates for opioids and stimulant drugs are substantially higher in men than in women: state-level analysis","volume":"48","author":"Butelman","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2026.113192_bib5","article-title":"Polydrug overdose mortality caused by synthetic opioids and stimulants: current sex- and age-specific trajectories in United States national data for 2018-2024","author":"Butelman","year":"2025","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2026.113192_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2025.2537039","article-title":"Overdoses with xylazine and fentanyl recorded in Pennsylvania's overdose information network: an analysis of law enforcement\/first responder-reported overdose response","author":"Cano","year":"2025","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2026.113192_bib7","unstructured":"CFSRE, 2023Drug checking quarterly report: Q1 and Q2 2023, Philadelphia, PA, USA.Center for Forensic Science Research and Education."},{"key":"10.1016\/j.drugalcdep.2026.113192_bib8","series-title":"The growing threat of xylazine and its mixture with ilicit drugs","author":"DEA","year":"2022"},{"key":"10.1016\/j.drugalcdep.2026.113192_bib9","doi-asserted-by":"crossref","unstructured":"Escobar, J.B., Wainwright, J., Wang, X., Dergacheva, O., Kay, M.W., Bethea, J.R., Jain, V., Polotsky, V.Y., Mendelowitz, D., 2026. Oxytocin treats respiratory depression and reduces mortality from fentanyl and the combination of xylazine-fentanyl. bioRxiv.","DOI":"10.64898\/2026.02.23.702914"},{"key":"10.1016\/j.drugalcdep.2026.113192_bib10","author":"FDA","year":"2022"},{"issue":"32","key":"10.1016\/j.drugalcdep.2026.113192_bib11","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1523\/JNEUROSCI.0355-22.2022","article-title":"Age-induced changes in micro-opioid receptor signaling in the midbrain periaqueductal gray of male and female rats","volume":"42","author":"Fullerton","year":"2022","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.drugalcdep.2026.113192_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12954-025-01237-5","article-title":"Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024","volume":"22","author":"Gomez","year":"2025","journal-title":"Harm Reduct. J."},{"issue":"1","key":"10.1016\/j.drugalcdep.2026.113192_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/15563650.2024.2309326","article-title":"Evaluation of the relationship of xylazine and fentanyl blood concentrations among fentanyl-associated fatalities","volume":"62","author":"Hays","year":"2024","journal-title":"Clin. Toxicol. (Philos. )"},{"issue":"2","key":"10.1016\/j.drugalcdep.2026.113192_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0572","article-title":"Knowledge, preference, and adverse effects of xylazine among adults in substance use treatment","volume":"7","author":"Hochheimer","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.drugalcdep.2026.113192_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00000542-198110000-00006","article-title":"Tissue redistribution of fentanyl and termination of its effects in rats","volume":"55","author":"Hug","year":"1981","journal-title":"Anesthesiology"},{"issue":"26","key":"10.1016\/j.drugalcdep.2026.113192_bib16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.15585\/mmwr.mm7326a2","article-title":"Reported xylazine use among adults aged >\/=18 years evaluated for substance use treatment - United States, july 2022-september 2023","volume":"73","author":"Jiang","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"3","key":"10.1016\/j.drugalcdep.2026.113192_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650.2022.2159427","article-title":"Opioid overdoses involving xylazine in emergency department patients: a multicenter study","volume":"61","author":"Love","year":"2023","journal-title":"Clin. Toxicol. (Philos. )"},{"issue":"1","key":"10.1016\/j.drugalcdep.2026.113192_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharm."},{"issue":"2","key":"10.1016\/j.drugalcdep.2026.113192_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"6","key":"10.1016\/j.drugalcdep.2026.113192_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.drugalcdep.2026.113192_bib21","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.54354","article-title":"A new rat study suggests there may be a biologic explanation for higher fentanyl mortality in men than in women","author":"Raffa","year":"2024","journal-title":"Cureus 16(2) e54354"},{"issue":"2","key":"10.1016\/j.drugalcdep.2026.113192_bib22","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/29767342241265181","article-title":"Exploring xylazine awareness, health impacts, and harm reduction strategies: findings from a multimethods study in Lowell, Massachusetts","volume":"46","author":"Shrestha","year":"2025","journal-title":"Subst. Use Addctn J."},{"key":"10.1016\/j.drugalcdep.2026.113192_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1280289","article-title":"\"Tranq-dope\" overdose and mortality: lethality induced by fentanyl and xylazine","volume":"14","author":"Smith","year":"2023","journal-title":"Front Pharm."},{"key":"10.1016\/j.drugalcdep.2026.113192_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112799","article-title":"Mu-opioid mediated discriminative stimulus effects of fentanyl and xylazine: Dose-response and time-course studies","volume":"275","author":"Smith","year":"2025","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2026.113192_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111282","article-title":"Xylazine does not enhance fentanyl reinforcement in rats: A behavioral economic analysis","volume":"258","author":"St Onge","year":"2024","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.drugalcdep.2026.113192_bib26","first-page":"600","article-title":"Administration of substances to laboratory animals: routes of administration and factors to consider","volume":"50","author":"Turner","year":"2011","journal-title":"J. Am. Assoc. Lab Anim. Sci."},{"key":"10.1016\/j.drugalcdep.2026.113192_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112553","article-title":"Characterization of xylazine-related overdose deaths in Maryland (2020-2023)","volume":"268","author":"Wang","year":"2025","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2026.113192_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdcr.2023.04.016","article-title":"Severe cutaneous ulcerations secondary to xylazine (tranq): a case series","volume":"36","author":"Wei","year":"2023","journal-title":"JAAD Case Rep."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871626001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871626001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:40:40Z","timestamp":1794555640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871626001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S0376871626001730"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2026.113192","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose and age matter: Xylazine prevents age-dependent fentanyl lethality in rats","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2026.113192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113192"}}